You just read:

ARMO BioSciences Announces Encouraging Survival Data Observed in Patients with Advanced Pancreatic Cancer in Phase 1/1b Trial of Immunotherapy AM0010

News provided by

ARMO BioSciences, Inc.

Jun 03, 2017, 09:00 ET